US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Western Yilgarn NL (WYXO) 銘柄情報

Western Yilgarn NL (WYXO)

0.008

0.00

(0.00%)

終了 6月28日 3:00PM

Western Yilgarn NL (WYXO) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.008

( - )

買値

0.002

売値

0.002

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.008

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 132,603

発行済株式数

157,325,757

配当利回り

PER

-2.86

1 株当たり利益 (EPS)

-0.01

歳入

49.23k

純利益

-1.45M

Western Yilgarn NL engages in mineral exploration business in Western Australia. The company explores for nickel, copper, cobalt, PGE, gold, and lithium deposits. Its flagship project is the Julimar West Bauxite Project covers 349 square kilometers within the Darling Ranges approximately 75km northe... Western Yilgarn NL engages in mineral exploration business in Western Australia. The company explores for nickel, copper, cobalt, PGE, gold, and lithium deposits. Its flagship project is the Julimar West Bauxite Project covers 349 square kilometers within the Darling Ranges approximately 75km northeast of Perth. The company was formerly known as Pacific Bauxite Limited and changed its name to Western Yilgarn NL in July 2022. Western Yilgarn NL was incorporated in 2005 and is headquartered in West Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

westernyilgarn.com.au

本社

West Perth, Australia

設立

2026

Western Yilgarn NL is listed in the Materials sector of the オーストラリア証券取引所 with ticker WYXO. The last closing price for Western Yilgarn NL was AUD0.01. Over the last year, Western Yilgarn NL shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Western Yilgarn NL currently has 157,325,757 shares in issue. The market capitalisation of Western Yilgarn NL is AUD1.26 million. Western Yilgarn NL has a price to earnings ratio (PE ratio) of -2.86.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

WYXO - Frequently Asked Questions (FAQ)

What is the current Western Yilgarn NL share price?

The current share price of Western Yilgarn NL is AUD 0.008

How many Western Yilgarn NL shares are in issue?

Western Yilgarn NL has 157,325,757 shares in issue

What is the market cap of Western Yilgarn NL?

The market capitalisation of Western Yilgarn NL is AUD 1.26M

What is the 1 year trading range for Western Yilgarn NL share price?

Western Yilgarn NL has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Western Yilgarn NL?

The price to earnings ratio of Western Yilgarn NL is -2.86

What is the cash to sales ratio of Western Yilgarn NL?

The cash to sales ratio of Western Yilgarn NL is 95.88

What is the registered address of Western Yilgarn NL?

The registered address for Western Yilgarn NL is Level 2, 7 Havelock Street, West Perth, Western Australia, 6008

What is the Western Yilgarn NL website address?

The website address for Western Yilgarn NL is westernyilgarn.com.au

Which industry sector does Western Yilgarn NL operate in?

Western Yilgarn NL operates in the Mining sector

The-Shadow

The-Shadow 3分前

The 2013–2015 Inflection Point: During this specific window, the global video distribution landscape was in a state of high transition. The industry was moving toward 4K and specialized high-fidelity streaming, but the hardware decoding ecosystems for standard formats were not yet entirely locked do

BBANBOB

BBANBOB 3分前

Just get us our FCNCA stock and we will figure out what too do with it SELL It or HOLD IT

Wallstreeter$$$

Wallstreeter$$$ 7分前

And hw many of those before were prepped and submitted by Smith of Hogan Lovells!?.....oh right the ans is zero! Pretty sure he knows a whole lot more abt what the FDA wants compared to MK just winging it in the past.

brooktrail1933

brooktrail1933 8分前

Of course they could, but here's the quote from Beartrap:

"IMHO, the real question now is will Dr. Bosch release the decision on the MAA at this presentation?"

mm41

Introductory Macroeconomic Overview
When WE published our preliminary reviews of NVIDIA Corporation (Ticker: NVDA) in April and May 2026, our primary objective was to expose the superficiality of the consensus market narrative. Today, in late June 2026, as market euphoria is mechanically sust

namtae

namtae 11分前

How many shares did you top off in the 70s and 80's?

Must be quite a bit according to your posting history

learningcurve2020

learningcurve2020 11分前

All the PLD data in the world isn’t going to tell them why L worked on a small number of patients. LP was likely told to figure that out first then resume trials. That’s also why LL became a SA. Without that information, another trial, and combined with reasonable cost, UK Marketing approval at th

capgain

capgain 11分前

Same here, and what a great price! He sure seems like it.

walterc

walterc 13分前

they were accumulated over severall weeks by the market makers

mm41

Calling this 'fear-based' is a convenient way to dismiss a forensic balance sheet analysis. You’re trading off consensus narratives; I’m trading off what’s actually recorded in the filings. Let’s address your 'scrutiny':

On Receivables & Cash Flow: You claim DSO is 'stable' and 'no ve

BIOChecker4

BIOChecker4 16分前

Right, and Ern and the 70 other AD patients you claim are still alive and taking Blarcamesine every day even though the compassionate use program ended in 2024. Are these folks mixing their own batches of Blarcamesine in Ern’s basement?

Doc logic

Doc logic 16分前

brazen22,

Thank you for supplying that direct quote. Again, “authorities” is plural so the warning is warranted because FDA only “accepts” the SAP hence the caution that one or more of those “authorities” may not grant product APPROVAL based on that approach. This statement covers t

BBANBOB

BBANBOB 18分前

Could go on forever but I seriously doubt that it will

DA BOYZ which have enough money to seriously stir the POT want their money as well

Wallstreeter$$$

Wallstreeter$$$ 18分前

Anyone.....has the company ever indicated they're looking at uplisting?

BBANBOB

BBANBOB 19分前

I have said on multiple occasions here that IF none OF THE dates PRODUCE ANYTHING, then I will wait for closing of the "R" before I make any decisions as to if anything is or IS NOT coming back.
CBOA( indicated that we MAY VERY WELL HAVE TO WAIT for the "R" to be lifted before anything takes

theswordman

theswordman 19分前

Apologies. Do you find Hoffman is not doing as well as micky mouse mulholland and sidekick weed/wine.??

The 3 rounds of financing were linked .
So for #1-- Did you not like the Yorkville deal because of there are no warrants, derivatives, or other share classes asso

flipper44

flipper44 20分前

Scientific analysis with patient level data is not a distraction. If you can’t follow, spend that upcoming half hour on your rowing machine.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177739827

SSKILLZ1

SSKILLZ1 21分前

Pick 4 Contest #24 Contest Week 6 Results In

Hope everyone enjoys the stats and has fun in the contest. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-24-50633

NotTheRealBeeny

NotTheRealBeeny 21分前

I bet that's true of the others that recently showed up as well. They'll all disappear at the same time too. I'm sure it's coincidence.

SSKILLZ1

SSKILLZ1 21分前

Pick 4 Contest #24 Contest Week 6 Results In

Hope everyone enjoys the stats and has fun in the contest. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-24-50633

biotechinvestor1

biotechinvestor1 21分前

I agree. The sooner the better. Also while they are at it, they should replace the VP of IR who came from Antares. In over 30 years of experience as an investor in biopharma, I have not seen one with such poor performance.

Wallstreeter$$$

Wallstreeter$$$ 23分前

Have to agree with you on that one. Its very possible IDE approval may not have a huge effect on the PPS, but....if the right peeps hop onboard it could get real crazy on news. I guess w'ell see soon enuf.

ZZZ888

ZZZ888 23分前

gitreal

gitreal 24分前

He does it as a public service. Purely voluntary! Except for the free shares.

murrayhill

murrayhill 24分前

The Tokai "335" caught my eye;
that first guy was a guitar player, imo.

Western Yilgarn NL

JPMorgan GBP Ultra Short...

Desire Petroleum

Oxford Square Capital

Bmo Target Education 203...

Spinnaker Acquisitions

Bond 681%29apr31 Bond 68...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。